Status:
UNKNOWN
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Resectable Pancreatic Cancer
Adjuvant Chemoradiotherapy
Eligibility:
All Genders
18-90 years
Brief Summary
This is a prospective observation cohort study to evaluate efficacy of different types of adjuvant therapy strategies, including chemoradiotherapy, chemotherapy alone, or no adjuvant treatment, for pa...
Eligibility Criteria
Inclusion
- Age between 18 to 90 years.
- Received surgical resection of primary tumor.
- Histological diagnosis of pancreatic ductal adenocarcinoma.
- Signed informed consent.
Exclusion
- Active concomitant malignancy (Malignancy other than pancreatic cancer).
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04737551
Start Date
January 1 2020
End Date
December 31 2023
Last Update
February 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China, 200032